Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01504334|
Recruitment Status : Unknown
Verified February 2012 by Zuojun Xu, Beijing Kawin Technology Share-Holding Co., Ltd..
Recruitment status was: Recruiting
First Posted : January 5, 2012
Last Update Posted : February 7, 2012
Beijing Kawin Technology Share-Holding Co., Ltd.
Information provided by (Responsible Party):
Zuojun Xu, Beijing Kawin Technology Share-Holding Co., Ltd.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||November 2012|
|Estimated Study Completion Date :||March 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):